
Sabkind Pharmaceuticals India Private Limited
About Sabkind Pharmaceuticals India Private Limited
Data last updated:
Sabkind Pharmaceuticals India Private Limited is a private limited company based in Mysore, Karnataka, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 03 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33110KA2013PTC069969. Its GSTIN is 29AAVCS6238G1ZN (Karnataka).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Kanthi Mallaiah and Ravi Ranganath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mysore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹73.77 Lakh (net margin 7.2%) and EBITDA of ₹92.78 Lakh (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 726% over three years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sabkind Pharmaceuticals India Private Limited's registered office is in Mysore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo C – 69 First Floor, Industrial Area, Mysore, Karnataka, India – 570020
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Sabkind Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sabkind Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sabkind Pharmaceuticals India Private Limited, buy the company report.
Financials of Sabkind Pharmaceuticals India Private Limited
FY 2025 filings availableSabkind Pharmaceuticals India Private Limited reported revenue of ₹10.2 Cr (up 255% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 726% over three years, including 255% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹92.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 7.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sabkind Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Sabkind Pharmaceuticals India Private Limited
Sabkind Pharmaceuticals India has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanthi Mallaiah Also directs: Cadell Health Care Private Limited | Director | 25 Jan 2023 | 3 Years 9 Months | Current |
| Ravi Ranganath Also directs: Cadell Health Care Private Limited | Director | 15 Apr 2015 | 11 Years 6 Months | Current |
Auditor
Sabkind Pharmaceuticals India Private Limited is audited by B. Ashwin & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. Ashwin & Co. | FY 2017 | 00258S |
Shareholding
The shareholding of Sabkind Pharmaceuticals India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sabkind Pharmaceuticals India Private Limited, buy the company report.
Legal cases
Sabkind Pharmaceuticals India Private Limited has 1 court case on record: 1 filed by Sabkind Pharmaceuticals India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, MYSURU, Karnataka | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Sabkind Pharmaceuticals India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sabkind Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sabkind Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAVCS6238G1ZN | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sabkind Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Sabkind Pharmaceuticals India Private Limited has 8 board changes on record since 2015: 2 appointments and 6 cessations. The latest: Kanthi Mallaiah ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Sabkind Pharmaceuticals India is an active private limited company based in Mysore, Karnataka, India. The company works in other wholesale, within the trading industry. It was incorporated on 03 July 2013 (13+ years old) and is registered under CIN U33110KA2013PTC069969.
Sabkind Pharmaceuticals India has 2 current directors:
- Kanthi Mallaiah - Director
- Ravi Ranganath - Director
The latest financial statements of Sabkind Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sabkind Pharmaceuticals India is 29AAVCS6238G1ZN, registered in Karnataka.
The CIN (Corporate Identification Number) of Sabkind Pharmaceuticals India is U33110KA2013PTC069969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sabkind Pharmaceuticals India has 1 court case on record: 1 filed by the company.
Sabkind Pharmaceuticals India was incorporated on 03 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Kanthi Mallaiah ceased to be Additional Director on 29 Sep 2023. Kanthi Mallaiah was appointed as Director on 25 Jan 2023. Sollepura Lakkegowda Lalitha ceased to be Additional Director on 30 Sep 2016. Sabkind Pharmaceuticals India has 8 board changes on record in total.
The registered office of Sabkind Pharmaceuticals India is at No C – 69 First Floor, Industrial Area, Mysore, Karnataka, India – 570020.
Sabkind Pharmaceuticals India operates in the trading industry, in the other wholesale segment.

